BUPIVACAINE AND EPI

The contract pertains to the procurement of Bupivacaine and Epinephrine, identified under the National Stock Number 6505-01-189-3973, with a requested quantity of three units. This solicitation, numbered SPE2DP-26-T-3794, was issued by the Defense Logistics Agency under the Department of Defense. It was posted on June 14, 2026, with a response deadline set for June 22, 2026. The solicitation is categorized as a federal-level procurement but does not specify any set-aside type or NAICS code. Details about the place of performance and office address are not provided, and there is no designated point of contact listed. The procurement is accessible via the Defense Logistics Agency’s online portal, indicating the government's intent to secure these pharmaceuticals for military or related federal use. The absence of additional set-aside information suggests that the contract is open to all eligible suppliers within federal guidelines.